Taken together, the activation of AMPK (especially AMPKα1) is a key mediator linking obesity and impaired muscle regeneration, providing an effective drug target to facilitate muscle regeneration in obese and elderly populations7–9. Here, PRKAA1 is linked to obesity disorder.